In focus · trending topic

spotlight innovation

2 stories · following the connections

Spotlight Innovation Subsidiary Celtic Biotech Iowa Announces Results from Two Cohorts of Phase I Trial of Crotoxin for the Treatment of Cancer

By Nasdaq OMXApr 18, 2018, 12:48 PM UTC

Spotlight Innovation Subsidiary Celtic Biotech Iowa to Present Two Posters at 2018 American Association for Cancer Research (AACR) Annual Meeting

By Nasdaq OMXMar 28, 2018, 1:01 PM UTC